Real‐world outcomes of addition of insulin glargine 300 U/mL (Gla‐300) to glucagon‐like peptide‐1 receptor agonist (GLP‐1 RA) therapy in people with type 2 diabetes: The DELIVER‐G study

Bibliographic Details
Title: Real‐world outcomes of addition of insulin glargine 300 U/mL (Gla‐300) to glucagon‐like peptide‐1 receptor agonist (GLP‐1 RA) therapy in people with type 2 diabetes: The DELIVER‐G study
Authors: Bailey, Timothy S., Gill, Jasvinder, Jones S., Merwyn, Shenoy, Laxmi, Nicholls, Charlie, Westerbacka, Jukka
Source: Diabetes, obesity & metabolism. 24(8):1617-1622
Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100155256008.0x000001&indx=1&recIds=ETOCvdc_100155256008.0x000001
Database: British Library Document Supply Centre Inside Serials & Conference Proceedings
More Details
ISSN:14628902
Published in:Diabetes, obesity & metabolism
Language:English